2007
DOI: 10.1016/j.ejphar.2006.10.023
|View full text |Cite
|
Sign up to set email alerts
|

Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 22 publications
0
21
0
Order By: Relevance
“…The primary pathology of NSAID-induced acute gastric mucosal damage is likely to be mucosal lesions due to inhibition of cyclooxygenase that prevents prostaglandin biosynthesis which in turn inhibits the release of mucus (Kauffman, 1989;Hudson et al, 1992), and reduction in gastric mucosal damage is likely to be mucosal lesions due to ischemia. The main mechanism by which NSAIDs reduce gastric mucosal blood flow is thought to be inhibition of COX-1 (Funatsu et al, 2007). This inhibition leads to a deficiency in endogenous prostaglandin E 2 and PGI 2 which in turn cause microcirculatory disturbances in the gastric mucosa (Shorrock & Rees, 1989).…”
Section: Discussionmentioning
confidence: 99%
“…The primary pathology of NSAID-induced acute gastric mucosal damage is likely to be mucosal lesions due to inhibition of cyclooxygenase that prevents prostaglandin biosynthesis which in turn inhibits the release of mucus (Kauffman, 1989;Hudson et al, 1992), and reduction in gastric mucosal damage is likely to be mucosal lesions due to ischemia. The main mechanism by which NSAIDs reduce gastric mucosal blood flow is thought to be inhibition of COX-1 (Funatsu et al, 2007). This inhibition leads to a deficiency in endogenous prostaglandin E 2 and PGI 2 which in turn cause microcirculatory disturbances in the gastric mucosa (Shorrock & Rees, 1989).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, we believe that to prevent aspirin-induced gastric mucosal injury, the 24-h intragastric pH should be maintained at higher than 4 by concomitant treatment with a PPI. The role of gastric acid in the pathogenesis of NSAIDinduced gastric mucosal injury was intensively studied by Funatsu et al [23]. They studied the gastric mucosal microcirculation in rats treated with diclofenac in the absence and presence of acid.…”
Section: Discussionmentioning
confidence: 99%
“…Studies using selective COX-1 or COX-2 inhibitors have indicated that the gastric ulcerogenic properties of NSAIDs are caused by inhibition of both COX-1 and COX-2 (Wallace et al, 2000;Tanaka et al, 2001). However, several reports suggest that other elements such as free radicals, disturbances of microcirculation, and hypermotility may be involved in the pathogenic mechanisms (Naito and Yoshikawa, 2006;Funatsu et al, 2007;Takeuchi, 2012). Furthermore, it has been reported that other risk factors, including diabetes and concomitant use of other agents, aggravate gastric lesions induced by NSAIDs (Pradeepkumar Singh et al, 2011;Takeuchi et al, 2011;Kwiecien et al, 2012).…”
Section: Introductionmentioning
confidence: 99%